Vect-Horus lands licensing pact with Novo Nordisk to improve drug delivery

The French biotech company Vect-Horus has licensed its technology to the Danish big pharma Novo Nordisk to deliver drug cargoes to undisclosed disease targets in three programs.

Related Keywords

Alexandre Tokay ,Brian Vandahl ,Drug Administration ,Novo Nordisk ,Markets Amp Regulations ,Emerging Markets ,Novo Nordisk Pharmatech ,Licensing Agreement ,Pharmaceutical Industry ,Drug Delivery ,Drug Delivery Systems ,